The Leadership Gap: Why Companies Struggle to Retain Top Executives
02/12/2025
No Comments
Companies invest millions in leadership development, yet many of their best executives leave within a few years. Why?
April 21, 2023: Moderna and IBM are collaborating to use generative artificial intelligence and quantum computing, advancing mRNA technology, the development at the core of the firm’s blockbuster Covid vaccine, the firm announced on Thursday.
“We are excited to be in with IBM to develop novel A.I. models to advance mRNA science, which prepares us for the era of quantum computing, and ready our firm for these game-changing technologies,” Moderna CEO Stephane Bancel stated.
Moderna shares dipped Thursday, while IBM’s stock was regarding flat.
The companies said they signed a deal for Moderna to access IBM’s quantum systems. According to Dr Dario Gil, IBM research director, those systems could accelerate Moderna’s discovery and creation of the recent messenger RNA vaccines and therapies.
The companies added that IBM would also provide experts who can help Moderna scientists use quantum technologies, unlike traditional computers, which store information as either zero that permits those systems to solve problems too complex for today’s computers.
Under the deal, Moderna’s scientists will have access to IBM’s generative A.I. model known as MoLFormer. Generative A.I. describes algorithms that can be used to create recent content based on the data they have been trained on.
The companies stated that Moderna would use IBM’s model to understand “the characteristics of the mRNA medicines” and design a recent class of vaccines and therapies.
The deal starts as Moderna navigates its post-pandemic boom driven by its mRNA Covid vaccine.
The Cambridge, Massachusetts-based company is a household name for its messenger RNA technology. It teaches human cells to produce a protein that initiates an immune response against a particular disease.
Moderna tries to harness that technology to target different diseases as the world emerges from the coronavirus and demand for blockbuster Covid vaccines and treatments slows.
The company is already developing a vaccine targeting the respiratory syncytial virus and a shot that can target different types of cancer combined with Merck’s immunotherapy Keytruda.
Companies invest millions in leadership development, yet many of their best executives leave within a few years. Why?
The most successful business leaders don’t just identify gaps in the market; they anticipate future needs before anyone else.
With technological advancements, shifting consumer expectations, and global interconnectedness, the role of business leaders
The leadership landscape is profoundly changing, influenced by technological advancements, shifting workforce expectations, and the need for adaptability in an unpredictable global environment.
In the fast-paced business world, corporate leaders often find themselves at the crossroads of risk and reward, where bold decisions …
Corporate leaders often navigate turbulent waters where failure is not just a possibility but an inevitable part of the journey …
Companies invest millions in leadership development, yet many of their best executives leave within a few years. Why?
February 12, 2025: Donald Trump has announced a 25% tariff on all steel and aluminum imports, reigniting trade tensions between the US and its key partners
February 11, 2025: The European Union is preparing retaliatory tariffs against the United States in response to newly imposed 25% U.S.
February 06, 2025: California and Texas are experiencing extreme weather, bringing widespread disruptions and safety concerns.
Leave us a message
Subscribe
Fill the form our team will contact you
Advertise with us
Fill the form our team will contact you
